Trial Identifier: | D8380C00001 |
Sponsor: | AstraZeneca |
Collaborator: |
Parexel International LLC
|
Start Date: | June 2025 |
Primary Completion Date: | April 2026 |
Study Completion Date: | April 2026 |
Condition: | Chronic Kidney Diseases |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
US, CA | Glendale, CA, US, 91206 |
US, TX | San Antonio, TX, US, 78215 |